Clinical Trials Directory

Trials / Completed

CompletedNCT02364687

Optimisation and Quantification of Contrast Enhanced Computed Tomography Myocardial Fibrosis Imaging

Optimisation and Quantification of Contrast Enhanced Computed Tomography

Status
Completed
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University of Edinburgh · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Detecting scarred heart muscle is important to diagnose and treat of a wide variety of heart conditions. Magnetic resonance imaging (MRI) can assess scarred heart muscle but it is time consuming, contraindicated for some patients and not tolerated by others. Computed tomography (CT) imaging has the potential to provide a rapid comprehensive assessment of the heart. This study will assess CT imaging of the heart muscle of patients who have previously undergone MRI of their heart. Using a state of the art CT scanner the investigators will develop a low radiation dose protocol to identify scarred heart muscle. The investigators will use and develop software techniques to analyse these images. This will enable us to develop a new way to identify and measure scarred heart muscle that will benefit patients with heart disease.

Conditions

Interventions

TypeNameDescription
RADIATIONComputed tomography late enhancement imaging

Timeline

Start date
2013-10-01
Primary completion
2015-12-01
Completion
2023-05-01
First posted
2015-02-18
Last updated
2023-06-27

Source: ClinicalTrials.gov record NCT02364687. Inclusion in this directory is not an endorsement.

Optimisation and Quantification of Contrast Enhanced Computed Tomography Myocardial Fibrosis Imaging (NCT02364687) · Clinical Trials Directory